PARM exhibits a distinct molecular profile characterized by a notably low frequency of BRAF and NRAS driver mutations, occurring in less than 10% of cases compared to over 50% in cutaneous melanoma (21). This evidence concerns the gene BRAF and cutaneous melanoma.